Hướng dẫn về việc sử dụng Apheresis điều trị trong thực hành lâm sàng—Cách tiếp cận dựa trên bằng chứng từ Ủy ban viết của Hiệp hội Apheresis Hoa Kỳ: Số đặc biệt thứ Sáu
Tóm tắt
Ủy ban viết số đặc biệt JCA của Hiệp hội Apheresis Hoa Kỳ (ASFA) có nhiệm vụ xem xét, cập nhật và phân loại các chỉ định cho apheresis điều trị. Bắt đầu từ Số đặc biệt ASFA năm 2007 (Phiên bản thứ Tư), ủy ban đã tích hợp xem xét có hệ thống và phương pháp dựa trên bằng chứng vào việc phân loại và đánh giá các chỉ định. Phiên bản thứ Sáu của Số đặc biệt ASFA đã cải thiện quy trình sử dụng y học dựa trên bằng chứng trong các khuyến nghị bằng cách áp dụng nhất quán các định nghĩa của hệ thống phân loại và GRADE, nhưng loại bỏ tiêu chí "mức độ bằng chứng" (từ Liên minh Chăm sóc Sức khỏe Đại học) đã được sử dụng trong các phiên bản trước do sự dư thừa giữa hệ thống GRADE và Liên minh Chăm sóc Sức khỏe Đại học. Bố cục và khái niệm chung của bảng thông tin đã được sử dụng trong các phiên bản thứ Tư và thứ Năm đã được duy trì trong phiên bản này. Mỗi bảng thông tin tóm tắt ngắn gọn bằng chứng cho việc sử dụng apheresis điều trị trong một thể bệnh cụ thể. Bài viết này bao gồm 78 bảng thông tin (tăng từ 2010) cho các chỉ định điều trị trong các danh mục ASFA từ I đến IV, với nhiều bệnh được phân loại có nhiều biểu hiện/situation lâm sàng mà từng cái được đánh giá và phân loại riêng biệt. J. Clin. Apheresis 28:145–284, 2013. © 2013 Wiley Periodicals, Inc.
Từ khóa
Tài liệu tham khảo
Bassler D, 2008, Evidencebased medicine targets the individual patient. Part 2: guides and tools for individual decision‐making, ACP J Club, 149, 1
Bassler D, 2008, Evidence based medicine targets the individual patient. Part 1: how clinicians can use study results to determine optimal individual care, ACP J Club, 148, 2
McLeod B, 2010, Apheresis: Principles and Practice
Murthy JM, 2002, Acute disseminated encephalomyelitis, Neurol India, 50, 238
RamachandraNair R, 2005, Plasmapheresis in childhood acute disseminated encephalomyelitis, Indian Pediatr, 42, 479
Assessment of plasmapheresis, 1996, Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology, Neurology, 47, 840
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain‐Barre syndrome, 1997, Plasma Exchange/Sandoglobulin Guillain‐Barre Syndrome Trial Group, Lancet, 349, 225
The utility of therapeutic plasmapheresis for neurological disorders, 1986, NIH Consensus Development, JAMA, 256, 1333
Efficiency of plasma exchange in Guillain‐Barre syndrome: role of replacement fluids, 1987, French Cooperative Group on Plasma Exchange in Guillain‐Barre syndrome, Ann Neurol, 22, 753, 10.1002/ana.410220612
Hughes RA, 2012, Intravenous immunoglobulin for Guillain‐Barré syndrome, Cochrane Database Syst Rev, 7, CD002063
Raphaël JC, 2012, Plasma exchange for Guillain‐Barré syndrome, Cochrane Database Syst Rev, 7, CD001798
Szczeklik W, 2008, Acute respiratory failure in patients with Guillain‐Barre syndrome and myasthenic crisis treated with plasmapheresis in the intensive care unit, Pol Arch Med Wewn, 118, 239
Silvestro G, 2000, A single institution's experience (1982–1999) with plasmaexchange therapy in patients with fulminant hepatic failure, Int J Artif Organs, 23, 454, 10.1177/039139880002300708
Horikoshi Y, 2012, Successful living donor liver transplantation for fulminant hepatic failure that manifested immediately after cesarean delivery, ASAIO J, 58, 174, 10.1097/MAT.0b013e3182444ed4
Huang YK, 2012, Randomized controlled study of plasma exchange combined with molecular adsorbent re‐circulating system for the treatment of liver failure complicated with hepatic encephalopathy, Hepatogastroenterology, 59, 1323
Blaha M, 2009, Cascade filtration in the therapy of the dry form of age‐related macular degeneration, Ther Apher Dial, 33, 453, 10.1111/j.1744-9987.2009.00752.x
Brunner R, 1996, Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption, and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome, Transfus Sci, 17, 493, 10.1016/S0955-3886(96)90083-1
Fell A, 2000, Effect of rheopheresis on visual function in patients with early age‐related macular degeneration, Invest Ophthalmol Vis Sci, 41, S181
Multicenter Investigation of Rheopheresis for AMD (MIRA‐1) Study Group, 2002, Multicenter prospective, randomized, double‐masked, placebo‐controlled study of rheopheresis to treat nonexudative age‐related macular degeneration: interim analysis, Trans Am Ophthalmol Soc, 100, 85
Pulido JS, 2006, Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA‐1) results, Trans Am Ophthalmol Soc, 104, 221
Soudavar F, 1998, Changes of retinal haemodynamics after elimination of high molecular weight proteins and lipids in patients with age‐related macular degeneration (AMD), Invest Ophthalmol Vis Sci, 39, S386
Swartz M, 1999, Treatment of non‐exudative age‐related macular degeneration using membrane differential filtration apheresis, Invest Ophthalmol Vis Sci, 40, S319
Widder RA, 2002, The treatment of age‐related macular degeneration (ARMD) with extracorporeal treatment procedures: A follow‐up of four years, Invest Ophthalmol Vis Sci, 43, 2906
Widder RA, 2000, Long‐term treatment of age‐related macular degeneration with extracorporeal apheresis, Ophthalmologe, 97, S172
Yeah JH, 2008, A case report of double‐filtration plasmapheresis for the treatment of age‐related macular degeneration, Ther Apher Dial, 12, 500, 10.1111/j.1744-9987.2008.00641.x
Monstad, 1979, Plasma exchange in motoneuron disease, A controlled study. J Neurol, 221, 59
Lind, 2006, Clinical and histologic determinants of renal outcome in ANCA‐Associated vasculitis: a prospective analysis of 100 patients with severe renal involvement, J Am Soc Nephrol, 17, 2264, 10.1681/ASN.2005080870
de Lind van Wijngaarden RAF, 2007, Hagen EC; for the European Vasculitis Study Group (EUVAS): Chances for renal recovery for dialysis‐dependent ANCA associated glomerulonephritis, J Am Soc Nephrol, 2189, 10.1681/ASN.2007010066
Little MA, 2004, Rapidly progressive glomerulonephritis: current and evolving treatment strategies, J Nephrol, 17, S10
Kitazawa K, 2008, Lupus nephritis associated with positive MPO‐ANCA in a patient with underlying autoimmune hemolytic anemia, Clin Exp Nephrol, 12, 393, 10.1007/s10157-008-0058-1
Merkel PA, 2009, EULAR recommendations for the management of primary small and medium vessel vasculitis, Ann Rheum Dis, 68, 310, 10.1136/ard.2008.088096
Walker RG, 1985, Clinical and morphological aspects of the management of crescentic anti‐glomerular basement membrane antibody (anti‐GBM) nephritis/Goodpasture's syndrome, Q J Med, 54, 75
Hunter C, 1981, Complete remission of idiopathic pure red cell aplasia. Case reports, S Afr Med J., 60, 68
Kiss JE, 2010, Apheresis: Principles and Practice, 3rd ed, 331
OrR NaparstekE ManiN SlavinS.Treatment of pure red‐cell aplasia following major ABO‐mismatched T‐cell‐depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis.Transpl Int1991;4:99–102.
AgliecoF ManickaratnamS BonaR KaplanAA.A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.Ther Apher Dial2008;12:185–189.
Azuma E, 1996, Recurrent cold hemagglutinin disease following allogeneic bone marrow transplantation successfully treated with plasmapheresis, corticosteroid and cyclophosphamide, Bone Marrow Transplant, 18, 243
Powers A, 2009, Hematology, Basic Principles and Practice, 645
Rosse WF, 2002, Blood: Principles and Practice of Hematology, 2nd ed, 1859
RuivardM TournilhacO MontelS FouilhouxAC QuainonF LenatA TravadeP PhilippeP.Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case‐control study.J Clin Apher2006;21:202–206.
Herman JH, 2010, Autoimmunity in transfusion babesiosis: a spectrum of clinical presentations, J Clin Apher, 25:358
Donati L, 1987, Prophylactic plasma exchange in burn treatment, Int J Tissue React, 9, 215
Stratta RJ, 1983, Plasma‐exchange therapy during burn shock, Curr Surg, 40, 429
Warden GD, 1984, The effect of exchange therapy on postburn lymphocyte suppression, Surgery, 96, 321
Ballew CC, 2005, Management of patients with preformed reactive antibodies who are awaiting cardiac transplantation, Am J Crit Care, 14, 46, 10.4037/ajcc2005.14.1.46
Hodge EE, 1994, Pretransplant removal of anti‐HLA antibodies by plasmapheresis and continued suppression on cyclosporine‐based therapy after heart‐kidney transplant, Transplant Proc, 26, 2750
John R, 1999, Intravenous immunoglobulin reduces anti‐HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular device recipients, Circulation, 100, 229, 10.1161/circ.100.suppl_2.Ii-229
Larson DF, 1999, Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients, J Extracorporeal Tech, 31, 177, 10.1051/ject/1999314177
Pollock‐BarZiv SM, 2007, Pediatric heart transplantation in human leukocyte antigen‐sensitized patients. Evolving management and assessment of intermediate‐term outcomes in a high‐risk population, Circulation, 116, I‐172
Asherson RA, 1992, The catastrophic antiphospholipid syndrome, J Rheumatol, 19, 508
Furmańczyk A, 2009, Catastrophic antiphospholipid syndrome, Pol Arch Med Wewn, 119, 427
GuimaraesCA SouzaEA MontenegroMA MarquesJF Jr. CendesF GuerreiroMM.Rasmussen's encephalitis: the relevance of neuropsychological assessment in patient's treatment and follow up.Arq Neuropsiquiatr2002;60(2-B):378–381.
Mehndiratta MM, 2012, Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy, Cochrane Database Syst Rev, 9, CD003906
Clark JA, 2010, Topical bovine thrombin: a 21‐year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System, Pharmacoepidemiol Drug Saf., 107, 10.1002/pds.1874
Eby C, 2003, Hemostatic complications associated with paraproteinemias, Curr Hematol Rep, 2, 388
Francesconi M, 1982, Plasmapheresis: its value in the management of patients with antibodies to factor VIII, Haemostasis, 11, 79
Huguet HC, 2004, Extracorporeal adsorption of anti‐factor VIII allo‐antibodies on randomly functionalized polystyrene resins, Thromb Haemost, 91, 259, 10.1160/TH03-07-0430
Kreuz W, 2003, Epidemiology of inhibitors and current treatment strategies, Haematologica, 88
Russo GE, 1996, Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment, Transfus Sci, 17, 499, 10.1016/S0955-3886(96)90084-3
Sanli H, 2011, The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome, J Drugs Dermatol, 10, 403
Wain EM, 2005, A randomized, open, crossover study to compare the efficacy of extracorporeal photopheresis with methotrexate in the treatment of primary cutaneous T‐cell lymphoma, Brit J Dermatol, 153, 10
Dandel M, 2010, Efficacy of immunoadsorption as bridge‐to‐transplant therapy in patients with idiopathic dilated cardiomyopathy and evidence of beta‐1 adrenoreceptor autoantibodies, J Heart Lung Transplant, 20, S1630
Nagatomo Y, 2008, Short‐term experience of immunoadsorption therapy for refractory heart failure due to dilated cardiomyopathy, J Card Fail, 14, S148, 10.1016/j.cardfail.2008.07.075
Beigel R, 2009, Homozygous familial hypercholesterolemia: long term clinical course and plasma exchange therapy for two individual patients and review of the literature, J Clin Apher, 24:219
Blazek M, 2007, Primary hemostasis in patients treated with LDL‐apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA‐100 analysis to rationalize therapeutic LDL‐apheresis procedure, Hematology, 12, 571, 10.1080/10245330701448370
Dairou F, 1998, Plasma exchange treatment for severe familial hypercholesterolemia: A comparison of two different techniques, Infus Ther, 23, 152
Gordon B, 1993, LDL apheresis in the treatment of severe hyperlipidemia, Primary Cardiol, 19, 53
Kamanabroo D, 1988, Plasma exchange in Type II hypercholesterolemia, Prog Clin Biol Res, 255, 347
Kamimura M, 2002, Improvements in artery occlusion by low‐density lipoprotein apheresis in a patient with peripheral arterial disease, Ther Apher, 6, 467, 10.1046/j.1526-0968.2002.00470.x
2010, Koziolek MJ, Henning U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Muller GA, Retrospective analysis of long‐term lipid apheresis in a single center. Ther Apher Dial (, 143
Lane D, 1995, Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy, Atherosclerosis, 11, 203, 10.1016/0021-9150(94)05484-Z
Lane D, 1994, Changes in plasma lipid and apolipoprotein levels between heparin‐induced extracorporeal low‐density lipoprotein precipitation (HELP) treatments, Am J Cardiol, 75, 1124, 10.1016/S0002-9149(99)80743-7
Masin V, 2007, Optimization of therapeutic procedure during LDL‐apheresis verification of the computerized model in clinical practice, Transfus Apher Sci, 36, 39, 10.1016/j.transci.2006.10.004
Park JW, 1995, Regression of transplant coronary artery disease during chronic HELP therapy: a case study, Atherosclerosis, 115, 1, 10.1016/0021-9150(95)91034-O
Postiglione A, 1988, From plasma‐exchanged to LDL‐apheresis: new developments in the treatment of familial hypercholesterolemia, Contrib Infus Ther, 23, 74
Saku K, 1998, Long‐term effect of low‐density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow‐up study using coronary angiography, J Cardiol, 31, 239
Schwandt P, 2003, Lipid apheresis: the only therapeutic option for a very small group of cardiovascular patients with high low‐density lipoprotein cholesterol or lipopoprotein(a) blood concentrations, Ther Apher Dial, 7, 283, 10.1046/j.1526-0968.2003.00061.x
Thompson GR, 1988, Plasma exchange and LDL apheresis, Prog Clin Biol Res, 255, 311
Thompson GR, 1989, Plasmapheresis in familial hypercholesterolemia, Arteriosclerosis, 9, 152
Aalst‐Cohen E, 2004, Clinical, diagnostic and therapeutic aspects of (inherited) hypercholesterolemia, Drug Discov Today, 1, 165, 10.1016/j.ddmec.2004.09.007
Baeyer H, 2000, Outcome of patients on long term low‐density lipop‐rotein apheresis with membrane differential filtration: a case study in trhee patients 14 years on treatment, Ther Apher, 4, 386, 10.1046/j.1526-0968.2000.004005386.x
Braun N, 2008, Immunosuppressive treatment for focal segmental glomerulosclerosis in adults, Cochrane Database Syst Rev, CD003233
Cameron JS, 2003, Focal segmental glomerulosclerosis in adults, Nephrol Dial Transplant, 18, vi45, 10.1093/ndt/gfg1058
Deegens JK, 2008, Review on diagnosis and treatment of focal segmental glomerulosclerosis, Neth J Med, 66, 3
Newstead CG, 2003, Recurrent disease in renal transplants, Nephrol Dial Transplant, 18, vi68
Sharma M, 1999, "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma, J Am Soc Nephrol, 10, 552, 10.1681/ASN.V103552
Dignan FL, 2012, Efficacy of biomonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD, Bone Marrow Transplant, 47:824
Garban F, 2005, Extracorporeal chemophototherapy for the treatment of graft‐versus‐host disease: hematologic consequences of short‐term, intensive courses, Haematologica, 90, 1096
Greinix HT, 2006, The effect of intensified extracorporeal photochemotherapy on long‐term survival in patients with severe acute graft‐versus‐host disease, Haematologica, 91, 405
Chalopin JM, 1980, Treatment of IgA nephropathies with plasma exchanges alone, Kidney Int, 18, 135
Gaskell H, 1985, Henoch‐Schönlein purpura with severe ileal involvement responding to plasmapheresis, Int J Artif Organs, 8, 163, 10.1177/039139888500800311
Kauffmann RH, 1981, Plasmapheresis in rapidly progressive Henoch‐Schonlein glomerulonephritis and the effect on circulating IgA immune complexes, Clin Nephrol, 16, 155
McKenzie PE, 1979, Plasmapheresis in glomerulonephritis, Clin Nephrol, 12, 97
Pasquali S, 1983, Plasma exchange in rapidly progressive glomerulonephritis, Eur J Clin Invest, 13, A44
Pussell BA, 1978, Value of immune–complex assays in diagnosis and management. Lancet, 2, 359
Wortmann SB, 2006, Refractory severe intestinal vasculitis due to Henoch‐Schönlein Purpura: successful treatment with plasmapheresis, Acta Pediatr, 95, 622, 10.1080/08035250500509180
Abdel‐Razeq HN, 2004, Treating heparin‐induced thrombocytopenia, The unconventional way! Saudi Med J, 25, 1258
Blakeman B, 1999, Management of heparin‐induced thrombocytopenia: a cardiovascular surgeon's perspective, Semin Hematol, 36, 37
Chan MY, 2008, Identification and treatment of arterial thrombophilia, Curr Treat Options Cardiovasc Med, 10, 3, 10.1007/s11936-008-0001-5
Koster A, 2001, Some new perspectives in heparin‐induced thrombocytopenia type II, J Extra Corpor Technol, 33, 193, 10.1051/ject/2001333193
Manzano L, 1990, Plasmapheresis in heparin‐induced thrombocytopenia and thrombosis, Stroke, 21, 1236, 10.1161/str.21.8.1236b
Nagle EL, 2011, Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy, Ann Pharmacother, 45, e47, 10.1345/aph.1P785
Robinson JA, 1999, Plasmapheresis in the management of heparin‐induced thrombocytopenia, Semin Hematol, 36, 29
Thorp D, 1990, Plasma exchange and heparin‐induced thrombocytopenia, Prog Clin Biol Res, 337, 521
Mariani R, 2005, Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage, Haematologica, 90, 717
Tan D, 2005, Therapeutic leukapheresis in hyperleukocytic leukaemias–the experience of a tertiary institution in Singapore, Ann Acad Med Singapore, 34, 229, 10.47102/annals-acadmedsg.V34N3p229
Bolan C, 2002, Intensive, long‐term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy, J Clin Endocrinol Metab, 87, 380, 10.1210/jcem.87.1.8176
Chait A, 1992, Chylomicronemia syndrome, Adv Intern Med, 37, 249
Bloch KJ, 1973, Hyperviscosity syndromes associated with immunoglobulin abnormalities, Semin Hematol, 10, 113
Buskard NA, 1977, Plasma exchange in the long‐term management of Waldenstrom's macroglobulinemia, Can Med Assoc J, 117, 135
Hoffkes HG, 1995, Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenstrom's type, Clin Nephrol, 43, 335
MacKenzie MR, 1972, Macroglobulinemia: an analysis for forty patients, Blood, 39, 874, 10.1182/blood.V39.6.874.874
Mod A, 1981, Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases, Haematologia (Budap), 14, 49
Reinhart WH, 1992, Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenstrom and multiple myeloma: influence on blood rheology and the microcirculation, J Lab Clin Med, 119, 69
Russell JA, 1977, Plasma exchange in malignant paraproteinemias, Exp Hematol, 5, 105S
Skoog WA, 1962, Metabolic balance study of plasmapheresis in a case of Waldenstrom's macroglobulinemia, Blood, 19, 425, 10.1182/blood.V19.4.425.425
Jindal K, 1999, management of idiopathic cresentic and diffuse proliferative glomerulonephritis: evidence‐based recommendations, Kidney Int, 55, S33, 10.1046/j.1523-1755.1999.07005.x
Levy JB, 1997, Still a role for plasma exchange in rapidly progressive glomerulonephritis?, J Nephrol, 10, 7
Little MA, 2004, Rapidly progressive glomerulonephritis: Current and evolving treatment strategies, J Nephrol, 17, S10
Sakellariou G, 1985, Plasma exchange (PE) treatment of rapidly progressive glomerulonephritis (RPGN), Life Support Syst, 3, 365
Stratta P, 1983, Plasma exchange in immune complex glomerulonephritis: clinical and immunological correlations, Int J Artif Organs, 6, 27
Thysell H, 1983, Improved outcome in rapidly progressive glomerulonephritis by plasma exchange treatment, In J Artif Organs, 6, 11
Walters G, 2008, Interventions for renal vasculitis in adults, Cochrane Database Syst Rev, 16, CD003232
Berchtold P, 1989, Therapy of chronic idiopathic thrombocytopenic purpura in adults, Blood, 74, 2309, 10.1182/blood.V74.7.2309.2309
Handelsman H, 1990, Protein A columns for the treatment of patients with idiopathic thrombocytopenic purpura and other indications, Health Technol Assess Rep, 1
Guthrie TH, 1989, Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients, Semin Hematol, 26, 3
Nakhoul IN, 2006, Management of adult idiopathic thrombocytopenic purpura, Clin Adv Hematol Oncol, 4, 136
Chalopin JM, 1984, Plasma exchange in severe IgA nephropathies: a prospective randomized trial, Ann Med Interne, 135, 33
Chalopin JM, 1983, Plasma exchange and IgA nephropathies, Eur J Clin Invest, 13, A45
Coppo R, 1985, Plasma exchange in primary IgA nephropathy and Henoch‐Schönlein syndrome nephritis, Plasma Ther Transfus Technol, 6, 705
Hene RJ, 1982, Plasmapheresis in nephropathy of Henoch‐Schönlein purpura and primary IgA nephropathy, Kidney Int, 22, 409
Roccatello D, 1995, Report on intensive treatment of extracapillary glomerulonephritis with focus on cresentic IgA nephropathy, Nephrol Dial Transplant, 10, 2054
Simon P, 1983, Disappearance of the mesangial IgA in IgA nephropathies after plasma‐exchanges (PE), Eur J Clin Invest, 13, A45
Dau PC, 1981, Plasmapheresis in idiopathic inflammatory myopathy, Experience with 35 patients. Arch Neurol, 38, 544
Jost WH, 1991, Therapeutic approaches to Lambert‐Eaton myasthenic syndrome in the intra‐individual comparison, Wien Klin Wochenschr, 103, 629
Keogh M, 2011, Treatment for Lambert‐Eaton myasthenic syndrome, Cochrane Database Syst Rev, CD003279
Lambert EH, 1956, Defect of neuromuscular conduction associated with malignant neoplasms, Am J Physiol, 187, 612
Newsom‐Davis J, 1982, Lambert‐Eaton myasthenic syndrome: electro‐ physiological evidence for a humoral factor, Muscle Nerve, 5, S17
Bambauer R, 1995, LDL‐apheresis in treatmet of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein(a) levels, Transfus Sci, 16, 375
Gelas T, 2011, ABO‐incompatible pediatric liver transplantation in very small recipients: Birmingham's experience, Pediatr Transplant, 15:706
Available at:http://optn.transplant.hrsa.gov: Accessed February 12 2013.
Yagci G, 2005, Successful ABO‐incompatible liver transplantation with pre‐ and postoperative plasmapheresis, triple immunosuppression, and splenectomy for fulminant hepatic failure, Exp Clin Transplant, 3, 390
Badesch DB, 1998, Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection, J Heart Lung Transplant, 17, 415
Organ procurement and transplantation network (OPTN)/Scientific registry of transplant recipients (SRTR)2010Annual Report. Available at:http://www.srtr.org/annual_reports/2010/1204_rec‐tx‐proc‐ty_lu.htm
Villanueva J, 2000, Extracorporeal photopheresis for the treatment of lung allograft rejection, Ann Transplant, 5, 44
Achavanuntakul B, 2001, Exchange transfusion in severe falciparum malaria: a simple method modified from hemodialysis circuit, J Med Assoc Thai, 84, 314
Deshpande A, 2003, Red cell exchange using cell separator (therapeutic erythrocytapheresis) in two children with acute severe malaria, J Assoc Physicians India, 51, 925
Molla S, 2001, Role of exchange transfusion in patients with severe Falciparum malaria: report of six cases, Haematologica, 86, 208
Sighinolfi L, 1990, Treatment of cerebral malaria by erythrocyte exchange, Recenti Prog Med, 81, 804
Chuncharunee S, 1997, Levels of serum tumor necrosis factor alpha in relation to clinical involvement and treatment among Thai adults with Plasmodium falciparum malaria, J Med Assoc Thai, 80, S72
Gulprasutdilog S, 1999, Exchange transfusion in severe falciparum malaria, J Med Assoc Thai, 82, 1
Looareesuwan S, 1990, Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature, Q J Med, 75, 471
Pinanong M, 1997, Exchange transfusion therapy in severe complicated malaria, J Med Assoc Thai, 80, 332
Srichaikul T, 1993, Exchange transfusion therapy in severe complicated malaria, Southeast Asian J Trop Med Public Health, 24, 100
Ende J, 1994, Twelve patients with severe malaria treated with partial exchange transfusion. Comparison between mathematically predicted and observed effect on parasitaemia, Trop Geogr Med, 46, 340
Available at:http://www.cdc.gov/malaria/diagnosis_treatment/index.html; Accessed on March 15 2013.
Available at:http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html; Accessed on March 15 2013.
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis, 1991, The Canadian Cooperative Multiple Sclerosis Study Group, Lancet, 337, 441, 10.1016/0140-6736(91)93389-Q
Khatri BO, 2009, Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function, Neurology, 72, 401, 10.1212/01.wnl.0000341766.59028.9d
Meca‐Lallana JE, 2003, Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study, Revista de Neurol, 37, 917
Gajdos P, 2002, Plasma exchange for myasthenia gravis, Cochrane Database Syst Rev, CD002275
Gajdos P, 2008, Intravenous immunoglobulin for myasthenia gravis, Cochrane Database Syst Rev, 10.1002/14651858.CD002277.pub3
Gajdos P, 1983, Long‐term effects of plasma exchange in myasthenia. Results of a randomized study, Presse Med, 12, 939
Goel SK, 2011, El‐Ghoroury M. Myeloma cast nephropathy: a rare cause of primary renal allograft dysfunction.Transplant Proc, 2784
Gupta D, 2010, Role of plasmapheresis in the management of myeloma kidney: a systematic review. Hemodial Int, 14, 355
Hay SN, 2002, Plasma exchange for rapidly progressive myeloma kidney, Abstract. J Clin Apher, 17, 142
Johnson WJ, 1990, Treatment of renal failure associated with multiple myeloma, Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med, 150, 863
Knudsen LM, 2000, Renal failure in multiple myeloma: reversibility and impact on the prognosis, Nordic Myeloma Study Group. Eur J Haematol, 65, 175, 10.1034/j.1600-0609.2000.90221.x
Locatelli F, 1980, Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma, Proc Eur Dial Transplant Assoc, 17, 690
Pasquali S, 1985, Plasma exchange therapy in rapidly progressive renal failure due to multiple myeloma, Int J Artif Organs, 8, 27
Paul M, 1982, Plasmapheresis therapy in a patient with multiple myeloma, Can Med Assoc J, 127, 956
Raje NS, 2011, Case records of the Massachusetts General Hospital: Case 29 −2011: a 66‐year‐old woman with cardiac and renal failure, N Engl J Med., 22, 1129, 10.1056/NEJMcpc1100925
Zucchelli P, 1984, Plasma exchange therapy in acute renal failure due to light chain myeloma, Trans Am Soc Artif Intern Organs, 30, 36
Hofmann JC, 2005, Nephrogenic fibrosing dermopathy: response to plasma exchange, J Clin Apher, 20, 12
Pesek GD, 2006, Extracorporeal photopheresis (ECP), a promising treatment for nephrogenic fibrosing dermopathy (NFD), J Clin Apher, 21, 13
Available at:http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm124344.htm; Accessed on September 3 2012.
Bonnan M, 2011, Plasma exchange in severe attacks of neuromyelitis optica, Mult Scler Int, 2012, 1155
Rasulov AR, 1994, [Intensive therapy in bites of poisonous snakes], Anesteziol Reanimatol, 59
Rubik J, 2003, Clinical aspects of plasmapheresis therapy in children: single center experience, Pol Merkuriusz Lek, 14, 304
Szczepiorkowski ZM, 2003, Apheresis: Principles and Practice, 375
Valavi E, 2011, ADAMTS‐13 deficiency following Hemiscorpius lepturus scorpion sting, Saudi J Kidney Dis Transplant, 22, 792
Bloch MH, 2004, Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome, Obstet Gynecol, 104, 1174, 10.1097/01.AOG.0000128110.31784.c8
Dalmau J, 1992, Anti‐Hu–associated paraneoplastic encephalomyelitis/sensory neuronopathy, A clinical study of 71 patients. Medicine, 71, 59
Dalmau JO, 1997, Paraneoplastic syndromes affecting the nervous system, Semin Oncol, 24, 318
Graus F, 2007, Paraneoplastic neurological syndromes: diagnosis and treatment, Curr Opin Neurol, 20, 732
Mani R SS, 2004, Opsoclonus myoclonus syndrome: response to plasmapheresis, Indian Pediatr, 41, 499
Lunn MP, 2012, Immunopathy for IgM anti‐myelin‐associated glycoprotein paraprotein‐associated peripheral neuropathies, Cochrane Database Syst Rev, 5, CD002827
Guidelines for the diagnosis of rheumatic fever, 1992, Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association, JAMA, 268, 2069
Arnold PD, 2001, Is obsessive‐compulsive disorder an autoimmune disease?, Cmaj, 165, 1353
Gajdos P, 2003, Intravenous immunoglobulin for myasthenia gravis, Cochrane Database Syst Rev, CD002277
Lopez Y, 2007, Therapeutic plasma exchange (TPE) in a patient with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS), J Clin Apher, 22, 82
Sasson Y, 1997, Epidemiology of obsessive‐compulsive disorder: a world view, J Clin Psychiatry, 58, 7
Martin LK, 2009, Interventions for pemphigus vulgaris and pemphigus foliaceus, Cochrane Database Syst Rev (Online), CD006263
Tsuchida H, 2006, Effect of low‐density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P‐LAS), Int Angiol, 25, 287
Dick JPR, 1993, Hypokalemia in acute Refsum's disease, J R Soc Med, 86, 171, 10.1177/014107689308600319
Moser HW, 1980, Therapeutic trial of plasmapheresis in Refsum disease and in Fabry disease, Birth Defects Orig Artic Ser, 16, 491
Penovich PE, 1978, Advances in Neurology, 151
Siegmund JB, 1995, Cascade filtration in Refsum's disease, Nephrol Dial Transplant, 10, 117
Blaha M, 2002, The role of erythrocytapheresis in secondary erythrocytosis therapy, Clin Hemorheol Microcirc, 26, 273
Elliott MA, 2004, Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera, Curr Hematol Rep, 3, 344
Pollari G, 1999, The role of erythrocytapheresis in secondary erythrocytosis therapy, Clin Hemorheol Microcirc, 21, 353
Vecchio S, 2007, A comparison of the results obtained with traditional phlebotomy and with therapeutic erythrocytapheresis in patients with erythrocytosis, Blood Transfus, 5, 20
Ako S, 1999, Crow‐Fukase syndrome‐ immunoadsorption plasmapheresis effectively lowers elevated interleukin‐6 concentration, Nephrol Dial Transplant, 14, 419, 10.1093/ndt/14.2.419
Atsumi T, 1995, A case of Crow‐Fukase syndrome with elevated soluble interleukin‐6 receptor in cerebrospinal fluid. Response to double‐filtration plasmapheresis and corticosteroids, Acta Haematol, 93, 90, 10.1159/000203980
Arnold DM, Rossi's Principles of Transfusion Medicine, 344
Bussel J, 2008, Hematology: Basic Principles and Practice, 2083
Molochkov VA, 2012, Clinical and immunological aspects of extracorporeal photochemotherapy for psoriasis and psoriatic arthritis, Ter Arkh, 84, 69
Kirsten GF, 1995, The outcome of babies of mothers with severe rhesus incompatibility treated at Tygerberg Hospital, 1980–1993, S Afr Med J, 85, 1091
AuBuchon JP, 2008, Reducing the variation in performance of antibody titrations, Archives Pathol Lab Med, 132, 1194, 10.5858/2008-132-1194-RTVIPO
Available at:http://optn.transplant.hrsa.gov; Accessed on February 12th 2013.
Schultz SH, 2007, Schizophrenia: a review, Am Fam Physician, 75, 1821
Brandtzaeg P, 1985, Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients, Scand J Clin Lab Invest Suppl, 178, 53
Kumar A, 1998, Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis, Nephrol Dial Transplant, 13, 484, 10.1093/oxfordjournals.ndt.a027853
Kalff A., 2011, The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults, Br J Haematol, 154, 656
Ohene‐Frempong K, 2001, Indications for red cell transfusion in sickle cell disease, Semin Hematol, 38, 5, 10.1053/shem.2001.20139
Shao SH, 1995, Sickle cell intrahepatic cholestasis: approach to a difficult problem, Am J Gastroenterol, 90, 2048
Thurston GB, 2004, Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood, Clin Hemorheol Microcirc, 30, 83
Al‐Samak ZM, 2008, Assessment of perioperative transfusion therapy and complications in sickle cell disease patients undergoing surgery, Middle East J Anesthesiol, 19, 983
Cohen AR, 1992, A modified transfusion program for prevention of stroke in sickle cell disease, Blood, 7, 1657, 10.1182/blood.V79.7.1657.1657
Haberkern CM, 1997, Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group, Blood, 89, 1533
Kalff A., 2011, The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults, Br J Haematol, 154, 656
Navaid M., A palliative care approach in treating patients with sickle cell disease using exchange transfusion, Am J Hosp Palliat Care, 27, 215, 10.1177/1049909109356966
Ohene‐Frempong K, 2001, Indications for red cell transfusion in sickle cell disease, Semin Hematol, 38, 5, 10.1053/shem.2001.20139
Plah OS, 1991, Pain in sickle cell disease, rates and risk factors, NEJM, 325, 11, 10.1056/NEJM199107043250103
Vichinsky EP, 1995, A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease, NEJM, 333:206
Alpa M, 2011, Apheresis as a rescue therapy in a severe case of sudden hearing loss, Int J Artif Organs, 34, 589, 10.5301/IJAO.2011.8548
Luetje CM, 1997, Plasmapheresis in autoimmune inner ear disease: long‐term follow‐up, Am J Otol, 18, 572
Adami R, 1993, Therapeutic thrombocytapheresis: a review of 132 patients, Int J Artif Organs, 16, 183, 10.1177/039139889301605s40
Beard ME, 1980, Control of thrombocytosis by plateletpheresis using a cell separator, N Z Med J, 91, 136
Koh LP, 2002, Four pregnancies in two patients with essential thrombocythaemia‐a case report, Ann Acad Med Singapore, 31, 353
Au WY, 2000, Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin, Haematologica, 85, 659
Boctor FN, 2006, Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin, Egypt J Immunol, 13, 95
McDonald SP, 1997, Quinine‐induced hemolytic uremic syndrome, Clin Nephrol, 47, 397
Patel TN, 2006, Use of ticlopidine and cilostazol after intracoronary drug‐eluting stent placement in a patient with previous clopidogrel‐induced thrombotic thrombocytopenic purpura: a case report, J Invasive Cardiol, 18, E211
Sabto JK, 1981, Hemodialysis, peritoneal dialysis, plasmapheresis and forced diuresis for the treatment of quinine overdose, Clin Nephrol, 16, 264
Saif MW, 2005, Hemolytic‐uremic syndrome associated with gemcitabine: a case report and review of literature, JOP, 6, 369
Piga M, 2008, Amiodarone‐induced thyrotoxicosis. A review, Minerva Endocrinol, 33, 213
Chrysomallis F, 1997, Plasmapheresis in toxic epidermal necrolysis, Int J Dermatol, 36, 218, 10.1046/j.1365-4362.1997.00192.x
Fritsch PO, 2003, Fitzpatrick's Dermatology in General Medicine (6e), 544
Nomura T, 2004, Plasma exchange; a promising treatment for toxic epidermal necrolysis with AIDS, AIDS, 18, 2446
Kamanabroo D, 1985, Plasmapheresis in severe drug‐induced toxic epidermal necrolysis, Arch Dermatol, 121, 1548, 10.1001/archderm.1985.01660120074023
Harrower T, 2006, A case of voltage‐gated potassium channel antibody‐related limbic encephalitis, Neurology, 2, 339
Rueff L, 2008, Voltage‐gated potassium channel antibody‐mediated syndromes: a spectrum of clinical manifestations, Rev Neurol Dis, 5, 65
Wintzen AR, 1994, Neuromyotonia with early response to plasmapheresis associated with proximal action myoclonus with late response to plasmapheresis, Muscle Nerve, 17, S221
Vernino S, Manual of Clinical and Laboratory Immunology, 2002